Mitochondrial quality control in health and cardiovascular diseases
Frontiers in Cell and Developmental Biology · 06.11.2023 · 11
DOI: 10.3389/fcell.2023.1290046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 06.11.2023. Verfasst von Asli E Atici und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, United S…. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 403 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are one of the primary causes of mortality worldwide. An optimal mitochondrial function is central to supplying tissues with high energy demand, such as the cardiovascular system. In addition to producing ATP as a power source, mitochondria are also heavily involved in adaptation to environmental stress and fine-tuning tissue functions. Mitochondrial quality control (MQC) through fission, fusion, mitophagy, and biogenesis ensures the clearance of dysfunctional mitochondria and preserves mitochondrial homeostasis in cardiovascular tissues. Furthermore, mitochondria generate reactive oxygen species (ROS), which trigger the production of pro-inflammatory cytokines and regulate cell survival. Mitochondrial dysfunction has been implicated in multiple CVDs, including ischemia-reperfusion (I/R), atherosclerosis, heart failure, cardiac hypertrophy, hypertension, diabetic and genetic cardiomyopathies, and Kawasaki Disease (KD). Thus, MQC is pivotal in promoting cardiovascular health. Here, we outline the mechanisms of MQC and discuss the current literature on mitochondrial adaptation in CVDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, United States.
- Infectious and Immunologic Diseases Research Center (IIDRC), Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Atici, A. E., Crother, T. R., & Noval Rivas, M. (2023). Mitochondrial quality control in health and cardiovascular diseases. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1290046
Vancouver
Atici AE, Crother TR, Noval Rivas M. Mitochondrial quality control in health and cardiovascular diseases. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1290046
BibTeX
@article{Atici2023,
author = {Atici, Asli E and Crother, Timothy R and Noval Rivas, Magali},
title = {Mitochondrial quality control in health and cardiovascular diseases},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1290046}
}
EUVIMED